These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19596358)

  • 1. The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature.
    Feifel D; Goldenberg J; Melendez G; Shilling PD
    Neuropharmacology; 2010 Jan; 58(1):195-8. PubMed ID: 19596358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
    Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
    Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.
    Shilling PD; Feifel D
    Pharmacol Biochem Behav; 2008 Oct; 90(4):748-52. PubMed ID: 18577396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
    Prus AJ; Hillhouse TM; LaCrosse AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():78-84. PubMed ID: 24275076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neurotensin receptor type 1 attenuates locomotor activity.
    Vadnie CA; Hinton DJ; Choi S; Choi Y; Ruby CL; Oliveros A; Prieto ML; Park JH; Choi DS
    Neuropharmacology; 2014 Oct; 85():482-92. PubMed ID: 24929110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
    Holly EN; Ebrecht B; Prus AJ
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):526-31. PubMed ID: 21277173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats.
    Keiser AA; Matazel KS; Esser MK; Feifel D; Prus AJ
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):541-7. PubMed ID: 25222546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.
    Hillhouse TM; Prus AJ
    Eur J Pharmacol; 2013 Dec; 721(1-3):201-7. PubMed ID: 24076181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin NTS
    Steele FF; Whitehouse SC; Aday JS; Prus AJ
    Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist.
    Sarhan S; Hitchcock JM; Grauffel CA; Wettstein JG
    Peptides; 1997; 18(8):1223-7. PubMed ID: 9396065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensorimotor gating in neurotensin-1 receptor null mice.
    Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
    Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog.
    Feifel D; Mexal S; Melendez G; Liu PY; Goldenberg JR; Shilling PD
    Neuropsychopharmacology; 2009 Jul; 34(8):2011-8. PubMed ID: 19322170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
    Hillhouse TM; Shankland Z; Matazel KS; Keiser AA; Prus AJ
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):548-56. PubMed ID: 25285844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
    Vadnie CA; Ayers-Ringler J; Oliveros A; Abulseoud OA; Choi S; Hitschfeld MJ; Choi DS
    Behav Brain Res; 2016 May; 305():8-17. PubMed ID: 26909848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat.
    Petrie KA; Bubser M; Casey CD; Davis MD; Roth BL; Deutch AY
    Neuropsychopharmacology; 2004 Oct; 29(10):1878-88. PubMed ID: 15150532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.
    Kim ER; Leckstrom A; Mizuno TM
    Behav Brain Res; 2008 Dec; 194(1):66-71. PubMed ID: 18639588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.